GB1417864A - Antihyertensive compositions - Google Patents

Antihyertensive compositions

Info

Publication number
GB1417864A
GB1417864A GB5666172A GB5666172A GB1417864A GB 1417864 A GB1417864 A GB 1417864A GB 5666172 A GB5666172 A GB 5666172A GB 5666172 A GB5666172 A GB 5666172A GB 1417864 A GB1417864 A GB 1417864A
Authority
GB
United Kingdom
Prior art keywords
isopropylamino
butylamino
tert
propanol
pivaloyloxypropoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5666172A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB1417864A publication Critical patent/GB1417864A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

1417864 Anti-hypertensive compositions SANDOZ Ltd 8 Dec 1972 [10 Dec 1971] 56661/72 Heading A5B An antihypertensive composition comprises as active agent a) an adrenergic #-blocking agent which is a compound of formula I wherein R is 4-indolyl; 4-(1-methylindolyl); 4- (3-methylindolyl); 4-(2-A-3-B-indolyl), wherein A is methyl, hydroxymethyl, carboxyl, carbalkoxy of 2 to 4 carbon atoms, carbamoyl, N-alkyl (of 1 to 4 carbon atoms) carbamoyl, N, N-dialkyl (of 1 to 4 carbon atoms) carbamoyl, carbazoyl or 3-alkyl (of 1 to 4 carbon atoms) carbazoyl, and B is hydrogen or methyl; 4-oxindolyl; 9-fluorenon-4-yl; 1-naphthyl; o-allylphenyl; o-allyloxyphenyl; m-tolyl; o-methylmercaptophenyl; o-phenoxyphenyl; pacetylaminophenyl; 4-acetoxy-3, 5, 6-trimethylphenyl; 4-indanyl; 5-(1, 2, 3, 4-tetrahydro)- 1-oxonaphthyl; or 2-chloro-5-methylphenyl, and R 1 is alkyl of 3 or 4 carbon atoms branched on the α carbon atom, and/or an ester thereof with an aliphatic carboxylic acid of 1 to 5 carbon atoms, other than 4-(2-hydroxy-3-isopropylaminopropoxy) indole, and b) clopamide. The compound of formula I may be selected from 4-(3-tert-butylamino-2-hydroxypropoxy) indole, 4-(2-hydroxy-3-isopropylaminopropoxy)-2-methylindole, 4-(tert-butylamino-2-hydroxypropoxy) - 2 - methylindole, 4-(3-isopropylamino - 2 - pivaloyloxypropoxy) indole, 4-(3-isopropylamino-2-pivaloyloxypropoxy)-2-methylindole, 4-(3-tert-butylamino -2- pivaloyloxypropoxy) - 2 - methylindole, 4-(3- tert-butylamino- 2 - pivaloyloxypropoxy) indole, 4-(2-hydroxy-3-isopropylaminopropoxy) oxindole, 4-(3-tert-butylamino-2-hydroxypropoxy) oxindole, 4-(3-isopropylamino-2-pivaloyloxypropoxy) oxindole, 4-(3-tert-butylamino-2- pivaloyloxypropoxy) oxindole, 4-(3-tert-butylamino-2-hydroxypropoxy)- 3 - fluorenone, 4- (2-hydroxy-3-isopropylaminopropoxy) - 9 - fluorenone, 4-(3-tert - butylamino-2-pivaloyloxy - propoxy)-9-fluorenone, 4-(3-isopropylamino-2- pivaloyloxypropoxy) - 9 - fluorenone, 1-isopropylamino-3-(1-naphthyloxy)- 2 - propanol, 1-(o-allylphenoxy) - 3 - isopropylamino-2-propanol, 1-(o-allyloxyphenoxy)-3-isopropylamino- 2 - propanol, 1-isopropylamino-3-(m-toloxy)-2- propanol, 5-(3-tert-butylamino-2-hydroxypropoxy)-3, 4-dihydro-1(2H)-naphthalenone, 1-(omethylmercaptophenoxy) - 3 - isopropylamino-2-propanol, 1-tert-butylamino-3-(2-chloro- 3-methylphenoxy)-2-propanol, 1-(isopropylamino)-3-(o - phenoxyphenoxy)-2-propanol, 4-(2- hydroxy-3-isopropylaminopropoxy) acetanilide, and 1-(3, 5, 6-trimethyl-4-acetoxyphenoxy)-3- isopropylamino-2-propanol.
GB5666172A 1971-12-10 1972-12-08 Antihyertensive compositions Expired GB1417864A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1804871 1971-12-10

Publications (1)

Publication Number Publication Date
GB1417864A true GB1417864A (en) 1975-12-17

Family

ID=4430039

Family Applications (2)

Application Number Title Priority Date Filing Date
GB5666172A Expired GB1417864A (en) 1971-12-10 1972-12-08 Antihyertensive compositions
GB2824575A Expired GB1418288A (en) 1971-12-10 1972-12-08 Anti-hypertensive compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB2824575A Expired GB1418288A (en) 1971-12-10 1972-12-08 Anti-hypertensive compositions

Country Status (6)

Country Link
AT (1) AT336176B (en)
AU (1) AU4987672A (en)
CY (1) CY991A (en)
GB (2) GB1417864A (en)
HK (1) HK11379A (en)
MY (1) MY7900115A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2638716A1 (en) 1976-08-27 1978-03-02 Ici Gmbh ANTIHYPERTENSIVA
FR2576788A1 (en) * 1985-02-05 1986-08-08 Sandoz Sa PHARMACEUTICAL COMPOSITIONS BASED ON 3-AMINOPROPOXYINDOLES
DE2660861C2 (en) * 1976-08-27 1988-02-04 Roehm Pharma Gmbh, 6100 Darmstadt, De

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (en) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh NEW CARBAZOLYL- (4) -OXY-PROPANOLAMINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
GB2593902B (en) * 2020-04-07 2022-04-13 Actimed Therapeutics Ltd Salt of a pharmaceutical compound

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2638716A1 (en) 1976-08-27 1978-03-02 Ici Gmbh ANTIHYPERTENSIVA
DE2660861C2 (en) * 1976-08-27 1988-02-04 Roehm Pharma Gmbh, 6100 Darmstadt, De
FR2576788A1 (en) * 1985-02-05 1986-08-08 Sandoz Sa PHARMACEUTICAL COMPOSITIONS BASED ON 3-AMINOPROPOXYINDOLES
GB2173399A (en) * 1985-02-05 1986-10-15 Sandoz Ltd Compositions containing 3-aminopropoxy-indoles for treating hypertension
AT393960B (en) * 1985-02-05 1992-01-10 Sandoz Ag METHOD FOR COMBINING A BETA ADRENO RECEPTOR BLOCKER AND A DIURETIC

Also Published As

Publication number Publication date
GB1418288A (en) 1975-12-17
AT336176B (en) 1977-04-25
CY991A (en) 1979-08-02
HK11379A (en) 1979-03-16
AU4987672A (en) 1974-06-13
ATA1040872A (en) 1976-08-15
MY7900115A (en) 1979-12-31

Similar Documents

Publication Publication Date Title
ES8700280A1 (en) An additive composition for increasing the conductivity of an organic polymer, an active hydrogen-containing composition containing the additive composition, and an organic polymer composition containing the additive composition.
KR850004388A (en) Manufacturing method of anti-inflammatory plaster
SE7612554L (en) AMINO ALCOHOL DERIVATIVES, AND PROCEDURES FOR MANUFACTURE OF SADANA
GB1260848A (en) Propanolamine derivatives
GB1417864A (en) Antihyertensive compositions
GB1190614A (en) Use of Alkyl 2-Benzimidazolecarbamates as Fungicides
GB1172320A (en) 0-(Phenylsulfonyl)-3-Indolyl Aliphatic Acids and Derivatives thereof, processes for preparing them, and Pharmaceutical Compositions containing them
GB1154743A (en) Aminoethanols
GB1356128A (en) Colour-former compositions for pressuresensitive recording
ES400742A1 (en) Tetrahydroquinoline phenoxyacetic acid derivatives
GB1288647A (en)
KR940005615A (en) Cycloheptimidazole Derivatives, Methods for Making the Same, and Therapeutic Agents Containing the Compound
ES388883A1 (en) 1-(2'-cyano-phenoxy)-2-hydroxy-3-ethylamino-propane and salts thereof
GB1419376A (en) Acaricides
GB1319346A (en) Heterocyclic substituted vinyl phsophates
ES390420A2 (en) Cyclopropane carboxylic acid derivatives
LaBrosse et al. Urinary tryptamine and indole-3-acetic acid excretion by schizophrenic patients: Use of the tryptamine/indole acetic acid ratio as an index of monoamine oxidase inhibition.
GB1028812A (en) Indole derivatives
GB1245155A (en) NOVEL 5-SUBSTITUTED-gamma-CARBOLINE DERIVATIVES AND THE SALTS THEREOF
ES304833A1 (en) Imidazole derivatives
ES408603A1 (en) 10-piperazinyl-dibenzo-b,f thiepins methods for their preparation and compositions containing them
JPS5312945A (en) Stabilized chlorine-containing resin composition
GB1356406A (en) Indole derivatives
ES409893A1 (en) Cyclopentene derivatives
ES455043A1 (en) 5-Alkylureido-1,3,4-thiadiazol-2-yl-sulfonyl-acetic acid derivatives

Legal Events

Date Code Title Description
PS Patent sealed
PE20 Patent expired after termination of 20 years

Effective date: 19921207